Australia’s Sigma Healthcare said on Wednesday that it had engaged in preliminary discussions for a potential acquisition of the British pharmacy chain Boots. The pharmaceutical wholesaler and retailer said it...
International News
Trump Media and TAE Technologies will not spin off Truth Social
Trump Media and Technology and TAE Technologies said on Wednesday that they had decided against spinning off Truth Social and certain other TMTG media assets into a new publicly listed company. TMTG, founded by U.S...
Russia fails for third time to sell off confiscated stake in gold miner UGC
The Russian state failed for a third time to auction a 67.2%stake in gold producer Uzhuralzoloto (UGC) that it had seized from its owner last year, the state auction website showed on Wednesday. The auction was...
GSK in talks to buy cancer biotech Nuvalent for more than $9 billion
UK pharmaceutical group GSK is in talks to buy cancer drugmaker Nuvalent for more than $9 billion, the Financial Times reported on Monday, citing people familiar with the matter. The companies were locked in...
Australia’s Sigma Healthcare says in preliminary discussions over Boots acquisition
Australia’s Sigma Healthcare said on Wednesday that it had engaged in preliminary discussions regarding a potential acquisition of the British pharmacy chain Boots, following recent media speculation. The...
Activist Ancora builds stake in Ashland, pushes for sale
Activist Ancora Alternatives has built a significant stake in Ashland Inc and wants the U.S. specialty chemicals company to sell itself, arguing that a transaction could boost its share price by at least 30%, according...
UK’s Boots in talks for $10 billion sale as owners plan to scrap IPO plans, FT reports
Boots is in talks with the billionaire Weston family and Australian pharmacy group Sigma Healthcare over a $10 billion (£7.5 billion) sale that would see the British health and beauty retailer scrap its plans for a...
Starbucks mulls options for Japan business, including stake sale, Bloomberg reports
Starbucks is weighing options for its Japanese business, including a stake sale, Bloomberg News reported on Tuesday. A stake sale might be valued at ¥400 billion ($2.5 billion) to ¥500 billion, possibly attracting...
GSK in talks to buy cancer biotech Nuvalent for more than $9 billion, FT reports
UK pharmaceutical group GSK is in talks to buy cancer drugmaker Nuvalent for more than $9 billion, the Financial Times reported on Monday, citing people familiar with the matter. Here are some details: The companies...
Bain Capital enters bidding war for Australia’s oOh!media after rival offers
Australian advertising firm oOh!media said on Tuesday it had received indicative takeover offers from Bain Capital and other financial sponsors, triggering a three-way bidding war with I Squared Capital and Pacific...
J&J to buy cancer drug technology developer Firefly Bio for $1 billion
Johnson & Johnson said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline. Firefly’s Firelink platform uses antibodies to deliver a protein...
Ingredion to buy UK’s Tate & Lyle for $3.6 billion
U.S. group Ingredion has struck a deal to buy Britain’s Tate & Lyle for £2.7 billion ($3.6 billion) in cash to create a leading speciality food and beverage ingredients company. The deal underscores how food...
